CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Accelerating Clinical Trials
Advancing research with digital-first clinical trials
AI and clinical trials
Improving decentralised trials with mobile research nursing
The new era of global patient recruitment
The next chapter of clinical trial services
Trusted clinical trial packaging services
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
AML cell therapy trials to watch in 2024 targeting GvHD
External controls can augment low populations in rare disease trials
Pipeline Moves: Approval prospects drop for Bayer’s cardiovascular drug after Phase III termination
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
BioVie reports protocol deviations in Phase III Alzheimer’s trial
4Moving Biotech shares innovative trial plans for GLP-1 osteoarthritis drug
Arrowhead seeks regulatory clearance for Type 1 myotonic dystrophy trial
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Candel downsizes to focus on oncolytic virus-based cancer therapies
External controls can augment low populations in rare disease trials
Royal Free London and UCL recruit patients for liver disease app trial
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Moderna mRNA patent revoked by EPO after Pfizer suit
Signal: Wegovy highlights UK’s complex relationship with private sector
Signal: Dutch health investor Gilde raises $804m for health startup fund
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
How to manage temperature-controlled shipments in unpredictable climate zones
How quality clinical monitoring oversight ensures the success of clinical trials
How to effectively incorporate PROMs in oncology trials
Events
Reports
Premium Insights
Newsletters
CT
All articles by Duncan West
Duncan West
Opinion
Opinion: why it is essential that SWIFT ejects Russia
Special Focus
Cyber Threats in the Global Financial Sector – Time to Worry?
Special Focus
Geopolitical situation in Ukraine will impact tourism across Europe
Covid-19
Gilead says leaked Covid-19 trial data of remdesivir inconclusive
Social Media
A deeper recession and slow recovery predicted by leading macroeconomic influencers
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
Covid-19
University of Waterloo to develop nasal vaccine for Covid-19
Covid-19
The four contests that will shape the post-Covid-19 world
View more
Most Popular
Pfizer’s weight loss drug hits primary endpoint in Phase IIb trial
The movement towards trial transparency
BlueSkeye AI to begin trial of AI mental health app for perinatal depression
